Distinct adiponectin profiles might contribute to differences in susceptibility to type 2 diabetes in dogs and humans

Domestic Animal Endocrinology

Volumn 41, Issue 2, 2011, Pages 67-73

  Verkest, K R ^a   Rand, J S ^a   Fleeman, L M ^a   Morton, J M ^a   Richards, A A ^a   Rose, F J ^a,b   Whitehead, J P ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Adipokine; Adiponectin; Canine; High molecular weight; Insulin sensitivity; Obesity

Indexed keywords

ADIPONECTIN; INSULIN;

ADOLESCENT; ADULT; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; COMPARATIVE STUDY; DENSITY GRADIENT CENTRIFUGATION; DOG; DOG DISEASE; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; OBESITY; PHYSIOLOGY; STATISTICAL MODEL;

ADIPONECTIN; ADOLESCENT; ADULT; ANIMALS; CENTRIFUGATION, DENSITY GRADIENT; DOG DISEASES; DOGS; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MALE; OBESITY; YOUNG ADULT;

CANIS FAMILIARIS;

EID: 79960103908     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2011.03.003     Document Type: Article

References (28)

1. Kim S.P., Ellmerer M., Van Citters G.W., Bergman R.N. Primacy of hepatic insulin resistance in the development of the metabolic syndrome induced by an isocaloric moderate-fat diet in the dog. Diabetes 2003, 52(10):2453-2460.
2. Chikamune T., Katamoto H., Ohashi F., Shimada Y. Serum lipid and lipoprotein concentrations in obese dogs. J Vet Med Sci 1995, 57(4):595-598.
3. Rand J.S., Fleeman L.M., Farrow H.A., Appleton D.J., Lederer R. Canine and feline diabetes mellitus: Nature or nurture?. J Nutr 2004, 134(8 Suppl):2072S-2080S.
4. Verkest K.R., Fleeman L.M., Rand J.S., Morton J.M. Evaluation of beta-cell sensitivity to glucose and first-phase insulin secretion in obese dogs. Am J Vet Res 2011, 72(3):357-366.
5. Yamauchi T., Kadowaki T. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases. Int J Obes 2008, 32:S13-S18.
6. Li S., Shin H.J., Ding E.L., Van Dam R.M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009, 302(2):179-188.
7. Kharroubi I., Rasschaert J., Eizirik D.L., Cnop M. Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun 2003, 312(4):1118-1122.
8. Huypens P., Moens K., Heimberg H., Ling Z., Pipeleers D., Van De Casteele M. Adiponectin-mediated stimulation of AMP-activated protein kinase (AMPK) in pancreatic beta cells. Life Sci 2005, 77(11):1273-1282.
9. Rakatzi I., Mueller H., Ritzeler O., Tennagels N., Eckel J. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 2004, 47(2):249-258.
10. Simpson F., Whitehead J.P. Adiponectin-it's all about the modifications. Int J Biochem Cell Biol 2010, 42(6):785-788.
11. Richards A.A., Colgrave M.L., Zhang J., et al. Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulation. Mol Endocrinol 2010, 24(1):229-239.
12. Brunson B.L., Zhong Q., Clarke K.J., et al. Serum concentrations of adiponectin and characterization of adiponectin protein complexes in dogs. Am J Vet Res 2007, 68(1):57-62.
13. Ishioka K., Omachi A., Sagawa M., et al. Canine adiponectin: cDNA structure, mRNA expression in adipose tissues and reduced plasma levels in obesity. Res Vet Sci 2006, 80(2):127-132.
14. Gayet C., Siliart B., Shibata H., Honjoh T., Saito M., Nguyen P. Adiponectin and leptin plasma levels: early markers in the time course of obesity-associated insulin resistance (IR) in dogs [abstract]. ACVIM Forum 2004.
15. Brunson B.L. Characterization of adiponectin in the canine [thesis] 2007, Auburn University, Auburn, AL.
16. German A.J., Hervera M., Hunter L., et al. Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs. Domest Anim Endocrinol 2009, 37(4):214-226.
17. Serisier S., Leray V., Poudroux W., Magot T., Ouguerram K., Nguyen P. Effects of green tea on insulin sensitivity, lipid profile and expression of PPAR{alpha} and PPAR{gamma} and their target genes in obese dogs. Br J Nutr 2008, 99(06):1208-1216.
18. Gayet C., Leray V., Saito M., Siliart B., Nguyen P. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-(gamma) target genes, in dogs. Br J Nutr 2007, 98(03):497-503.
19. Tsunoda M., Kobayashi N., Ide T., Utsumi M., Nagasawa M., Murakami K. A novel PPAR{alpha} agonist ameliorates insulin resistance in dogs fed a high-fat diet. Am J Physiol Endocrinol Metab 2008, 294(5):E833-E840.
20. Verkest K.R., Fleeman L.M., Morton J.M., Ishioka K., Rand J.S. Compensation for obesity-induced insulin resistance in dogs: assessment of the effects of leptin, adiponectin, and glucagon-like peptide-1 using path analysis. Domest Anim Endocrinol 2011, 41:24-34.
21. Laflamme D. Development and validation of a body condition score system for dogs. Canine Pract 1997, 22(4):10-15.
22. Finegood D.T., Pacini G., Bergman R.N. The insulin sensitivity index: correlation in dogs between values determined from the intravenous glucose tolerance test and the euglycaemic glucose clamp. Diabetes 1984, 33:362-368.
23. Richards A.A., Stephens T., Charlton H.K., et al. Adiponectin multimerization is dependent on conserved lysines in the collagenous domain: Evidence for regulation of multimerization by alterations in posttranslational modifications. Mol Endocrinol 2006, 20(7):1673-1687.
24. Omachi A., Ishioka K., Shibata H., Honjoh T., Kimura K., Saito M. Canine adiponectin: Measurement of its serum/plasma concentration by ELISA and effects of obesity (transl). Vet Biochem 2004, 41(1):31-37.
25. Kaser S., Tatarczyk T., Stadlmayr A., et al. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur J Clin Invest 2008, 38(11):827-834.
26. Wakshlag J., Struble A., Levine C., Bushey J., Laflamme D.P., Long G. Effects of weight loss on adipokines and markers of inflammation in dogs [abstract]. The Waltham International Nutritional Sciences Symposium Pet Nutrition - Art or Science? 2010, University of Cambridge, Cambridge, United Kingdom.
27. Gerich J.E. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?. Diabetes 2002, 51(Suppl 1):S117-S122.
28. Swarbrick M., Austrheim-Smith I., Stanhope K., et al. Circulating concentrations of high-molecular-weight adiponectin are increased following roux-en-y gastric bypass surgery. Diabetologia 2006, 49(11):2552-2558.